Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Профилактика йододефицитных состояний и аутоиммунные заболевания щитовидной железы
Профилактика йододефицитных состояний и аутоиммунные заболевания щитовидной железы
Абдулхабирова Ф.М. Профилактика йододефицитных состояний и аутоиммунные заболевания щитовидной железы. Consilium Medicum. 2014; 16 (4): 50–54.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Dunn JT. Seven deadly sins in confronting endemiciodine deficiency, and how to avoid them. Endocrinol Metab 1996; 81: 1332–5.
2. Lazarus J, Obuobie K. Thyroid disorders – an update. Postgr Med J 2000; 76: 529–36.
3. Allen EM, Appel MC, Braverman LE. The effect of iodine ingestion on development of spontaneous lymphocytic thyroiditis in the diabetic-prone BB/ W rat. Endocrinology 1986; 28: 157–63.
4. Голицин С.П., Бакалов С.А., Сердюк С.Е. и др. Кардиальные и эндокринные аспекты применения амиодарона в современной практике лечения нарушений ритма сердца. Под. ред. Е.И.Чазова, И.И.Дедова. М., 2012.
5. Teng W, Shan Z, Teng X et al. Effect of iodine intake on thyroid diseases in China. Engl J Med 2006; 354: 2783–93.
6. Loh K. Amiodarone-induced thyroid disorders: a clinical review. Postgrad Med J 2000; 76: 133–40.
7. Iervasi G, Clerico A, Bonini R et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997; 82: 275–80.
8. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid 1998; 8: 101–6.
9. Burgi H, Schaffner TH, Seiler JP. The toxicology of iodate: a review of the literature. Thyroid 2001; 11: 449–56.
10. Robison LM, Sylvester PW, Birkenfeld P et al. Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Health 1998; 55: 93–106.
11. WHO. The 58th World Health Assembly WHA58.24:Sustaining the elimination of iodine deficiency disorders. WHA58_24-en.pdf (accessed Nov 18, 2007).
12. McConahey WM, Keatimg FR, Beahrs OH et al. On the increasing occurrence of Hashimoto thyroiditis. J Clin Endocrinol Metab 1962; 22: 542–4.
13. Vollenweider R, Stolkin I, Hedinger C. Fokale Lymphozytare Thyreoiditis und Jodsalzprophylaxe. Vergleichende Untersuchungen an Strumare-sektaten des Institutes fur Pathologie der Universitat Zurich. Schweiz Med Wsehr 1982; 112: 482–8.
14. Burgi H, Baumgarther H, Steiger G. Gibt es eine obere Vertraglichkeitsgrenze deralimentaren Jodzufuhr. Schweiz Med Wochenschr 1982; 112: 2–7.
15. Fenzi GF, Giani C, Ceccarelli P et al. Role of autoimmune, familial factors in goiter prevalence. Studies performed in moderately endemic area. J Clin Invest 1986; 9: 161–4.
16. Laurberg P, Pedersen KM, Hreidarsson A et al. Iodine intake
and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765–9.
17. Kampe O, Janson R, Karlsson A. Effect of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1990; 70: 1014–8.
18. Kessler JH. The effect of supraphysiologiclevelsof iodine on patients with cyclic mastalgia. Breast J 2004; 10: 328–36.
19. Платонова Н.М. Йододефицитные заболевания (профилактика, диагностика, лечение и мониторинг). Автореф. дис. ... д-ра мед. наук. М., 2010.
20. Azizi F, Hedayati M, Rahmani M et al. Reappraisal of the risk of iodineinduced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005; 28: 23–9.
2. Lazarus J, Obuobie K. Thyroid disorders – an update. Postgr Med J 2000; 76: 529–36.
3. Allen EM, Appel MC, Braverman LE. The effect of iodine ingestion on development of spontaneous lymphocytic thyroiditis in the diabetic-prone BB/ W rat. Endocrinology 1986; 28: 157–63.
4. Голицин С.П., Бакалов С.А., Сердюк С.Е. и др. Кардиальные и эндокринные аспекты применения амиодарона в современной практике лечения нарушений ритма сердца. Под. ред. Е.И.Чазова, И.И.Дедова. М., 2012.
5. Teng W, Shan Z, Teng X et al. Effect of iodine intake on thyroid diseases in China. Engl J Med 2006; 354: 2783–93.
6. Loh K. Amiodarone-induced thyroid disorders: a clinical review. Postgrad Med J 2000; 76: 133–40.
7. Iervasi G, Clerico A, Bonini R et al. Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia. J Clin Endocrinol Metab 1997; 82: 275–80.
8. Dunn JT, Semigran MJ, Delange F. The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid 1998; 8: 101–6.
9. Burgi H, Schaffner TH, Seiler JP. The toxicology of iodate: a review of the literature. Thyroid 2001; 11: 449–56.
10. Robison LM, Sylvester PW, Birkenfeld P et al. Comparison of the effects of iodine and iodide on thyroid function in humans. J Toxicol Environ Health 1998; 55: 93–106.
11. WHO. The 58th World Health Assembly WHA58.24:Sustaining the elimination of iodine deficiency disorders. WHA58_24-en.pdf (accessed Nov 18, 2007).
12. McConahey WM, Keatimg FR, Beahrs OH et al. On the increasing occurrence of Hashimoto thyroiditis. J Clin Endocrinol Metab 1962; 22: 542–4.
13. Vollenweider R, Stolkin I, Hedinger C. Fokale Lymphozytare Thyreoiditis und Jodsalzprophylaxe. Vergleichende Untersuchungen an Strumare-sektaten des Institutes fur Pathologie der Universitat Zurich. Schweiz Med Wsehr 1982; 112: 482–8.
14. Burgi H, Baumgarther H, Steiger G. Gibt es eine obere Vertraglichkeitsgrenze deralimentaren Jodzufuhr. Schweiz Med Wochenschr 1982; 112: 2–7.
15. Fenzi GF, Giani C, Ceccarelli P et al. Role of autoimmune, familial factors in goiter prevalence. Studies performed in moderately endemic area. J Clin Invest 1986; 9: 161–4.
16. Laurberg P, Pedersen KM, Hreidarsson A et al. Iodine intake
and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998; 83: 765–9.
17. Kampe O, Janson R, Karlsson A. Effect of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J Clin Endocrinol Metab 1990; 70: 1014–8.
18. Kessler JH. The effect of supraphysiologiclevelsof iodine on patients with cyclic mastalgia. Breast J 2004; 10: 328–36.
19. Платонова Н.М. Йододефицитные заболевания (профилактика, диагностика, лечение и мониторинг). Автореф. дис. ... д-ра мед. наук. М., 2010.
20. Azizi F, Hedayati M, Rahmani M et al. Reappraisal of the risk of iodineinduced hyperthyroidism: an epidemiological population survey. J Endocrinol Invest 2005; 28: 23–9.
Авторы
Ф.М.Абдулхабирова
ФГБУ Эндокринологический научный центр Минздрава России, Москва
ФГБУ Эндокринологический научный центр Минздрава России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.
